{"docid":"VWS-WOO-Spc-906956","collapsed":true,"count":1,"unchecked":0,"snapshots_total":1,"versions":[{"archive_id":"14622","bestandsnaam":"VWS-WOO-Spc-906956-Whitepaper_-_COVID-19_Vaccine_Themis.pdf","created_date":"2025-02-18 12:18:00","last_seen":"2025-02-18 12:18:00","from_file":"Besluit__dossier_nr_-a7d61ec8a82ef1585e3e622eb92c8eef5a53e63fecdbceb5a3a4168ddff40f49.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\Besluit__dossier_nr_-a7d61ec8a82ef1585e3e622eb92c8eef5a53e63fecdbceb5a3a4168ddff40f49.zip","snippet":"WHITEPAPER\nCOVID-19 Vaccine Based onFDA/EMA\nApproved Commercial-Scale Technology\nExecutive Summary\nInorder toreact toand overcome challengeslikethe current SARS-CoV-2 pandemic, safe and\nefficacious va","digest":"da0a4cc55c72","dupes":1,"date_to":"2025-02-18 12:18:00","date_from":"2025-02-18 12:18:00","unchecked":false}],"raw":[{"archive_id":"14622","bestandsnaam":"VWS-WOO-Spc-906956-Whitepaper_-_COVID-19_Vaccine_Themis.pdf","created_date":"2025-02-18 12:18:00","last_seen":"2025-02-18 12:18:00","from_file":"Besluit__dossier_nr_-a7d61ec8a82ef1585e3e622eb92c8eef5a53e63fecdbceb5a3a4168ddff40f49.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\Besluit__dossier_nr_-a7d61ec8a82ef1585e3e622eb92c8eef5a53e63fecdbceb5a3a4168ddff40f49.zip","snippet":"WHITEPAPER\nCOVID-19 Vaccine Based onFDA/EMA\nApproved Commercial-Scale Technology\nExecutive Summary\nInorder toreact toand overcome challengeslikethe current SARS-CoV-2 pandemic, safe and\nefficacious va","digest":"da0a4cc55c72"}],"filename":"Whitepaper - COVID-19 Vaccine Themis.pdf","truncated":false,"elapsed_ms":10}